Evidence map›Paper›PMID 35454303›Full record

ReviewMedicina (Kaunas, Lithuania)2022

Rare Cause of Severe Mitral Regurgitation after TAVI: Case Report and Literature Review.

Horațiu Moldovan, Bogdan-Ştefan Popescu, Elena Nechifor, Aida Badea, Irina Ciomaga, Claudia Nica, Ondin Zaharia, Daniela Gheorghiță, Marian Broască, Camelia Diaconu and 3 more

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Horațiu MoldovanFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-2241-279X
Bogdan-Ştefan PopescuBucharest Clinical Emergency Hospital, 014461 Bucharest, Romania.
Elena NechiforSanador Clinical Hospital, 011038 Bucharest, Romania.
Aida BadeaBucharest Clinical Emergency Hospital, 014461 Bucharest, Romania.
Irina CiomagaSanador Clinical Hospital, 011038 Bucharest, Romania.
Claudia NicaBucharest Clinical Emergency Hospital, 014461 Bucharest, Romania.
Ondin ZahariaFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Daniela GheorghițăFaculty of Materials Science and Engineering, Politehnica University of Bucharest, 060042 Bucharest, Romania.ORCID 0000-0003-3660-8926
Marian BroascăBucharest Clinical Emergency Hospital, 014461 Bucharest, Romania.
Camelia DiaconuFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0001-6837-260X
Cătălina Parasca"Prof. Dr. C.C. Iliescu" Institute for Cardiovascular Diseases, 022328 Bucharest, Romania.
Ovidiu ChioncelFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Vlad Anton IliescuFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Clinical Emergency Hospital Bucharest · ROCarol Davila University of Medicine and Pharmacy · ROInstitutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu" · ROUniversitatea Națională de Știință și Tehnologie Politehnica București · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-procedure mitral regurgitation (MR) is a frequent coexistent finding in patients undergoing transcatheter aortic valve replacement (TAVR), and most of them (up to 55%) experience a significant improvement in MR after the procedure. Although seldom described, mitral valve perforation after TAVR is a potentially serious complication that physicians should be aware of, as moderate or severe MR in TAVR recipients is associated with a high early mortality rate. We herein describe the case of a 65-year-old man presenting with worsening heart failure symptoms 5 months after TAVR due to an intraprocedural anterior mitral leaflet perforation and discuss the diagnostic process and therapeutic course of the case. Furthermore, we draw attention to the essential role of echocardiography in the management of TAVR procedures, taking into account its ability in detecting early complications, and emphasize the value of CT as a main determinant to predict long-term MR improvement after TAVR and to assess the potential candidates for double valve repair with percutaneous techniques.

Indexed as

Aortic Valve StenosisMitral Valve InsufficiencyAgedAortic ValveHumansMaleSeverity of Illness IndexTreatment Outcomeanterior mitral leaflet (AML) perforationmitral regurgitation (MR)transcatheter aortic valve replacement (TAVR)

Identifiers

PMID35454303
PMCPMC9031139
OpenAlexW4220727501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.